The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was JOD 2.04 million compared to JOD 3.71 million a year ago. Net loss was JOD 2.17 million compared to JOD 0.545556 million a year ago.

Basic loss per share from continuing operations was JOD 0.031 compared to JOD 0.008 a year ago.